Apnimed Q2 EPS $3.91 Beats $(0.34) Estimate, Sales $12.080M
Apnimed (NASDAQ:APMD) reported quarterly earnings of $3.91 per share which beat the analyst consensus estimate of $(0.34) by 1250 percent. The company reported $12.080 million in sales this quarter.
Apnimed made way more money than experts thought it would—earning $3.91 per share instead of losing money. When a company does much better than people expected, it's a good sign they might be running their business really well.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.